The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations.
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000648:ultrastructure; D003010:Clorgyline / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D010627:Phenethylamines / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012642:Selegiline / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism*; D013347:Subcellular Fractions / Q000378:metabolism; D013574:Synaptosomes / Q000378:metabolism*
D010627:Phenethylamines; D011437:Propylamines; D012642:Selegiline; D012701:Serotonin; D003010:Clorgyline; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine